Vaccine developers seek to help group hit hardest by Covid-19: the elderly

• Pharmaceutical companies working on vaccine candidates have included older adults in large phase three trials
• The immune system ages just like the rest of the body and this can affect vaccine safety or efficiency in older adults, immunologist says